Mr Maan Kasmiya

About

• Biography icon plus

  Following completing specialist training in the UK as an ophthalmologist, Mr Kasmiya joined King’s College Hospital as substantive consultant taking the lead for Diabetic Eye Screening at Bromley in south London area, the DESP program is in partnership with Guy’s and St Thomas’ Hospitals.
  
  In addition, his proactive role in medical and clinical researches and teaching prominent international researches related to eye diseases. As a result, he was honoured to be appointed as an honorary lecturer at the Imperial College London faculty, He is also a speaker at many ophthalmology meetings and is an examiner for the king's college University hospital.
  
  Since qualifying as a consultant, he has led retinal services in different trusts including Chelsea & Westminster Hospital and involved in anti VEGF injection treatment for Age related macular degeneration, Diabetic retinopathy, Laser treatment and Cataract Surgeries.
  
  In total, of more than 20 years of work experience as eye specialist, including more than two years quality fellowships,Mr Kasmiya has consolidated his clinical knowledge following performing thousands of cataracts surgeries and ability to use different type of lenses including multi-focal, toric and spheric IOL. Most of which were accomplished to the highest standards with very low complication rate, that are well below the national standard.
  
  His passion is in helping patients improving their sights and provide Professional and truthful advice alongside the best evidence practice in regards of their eye health

• Clinical interests icon plus

  Cataract Surgery,Medical Retina
  Intra-vitreal ANTI-VEGF Injections
  Age Related Macular Degeneration.AMD
  Retinal Vein Occlusion
  Laser Surgery
  Diabetic Eye Disease
  Ozurdex Implants 
  Eye Emergency
  

   

• Publications icon plus

  RESEARCH
  -STAR Study multi-Centre, factorial, randomised controlled trial to evaluate the safety and efficacy of focal delivery of radiation for the treatment of subfoveal choroidal neovascularization (CNV) associated with established wet age-related macular degeneration (AMD) alongside IVT (Lucentis) to reduce the frequency of injections, King’s College Hospitals NHS , UK, 2019
  
  -CANDEL Study, Multi-Centre, factorial, randomised controlled trial, explore the health and economic impact of a novel therapy for Diabetic Retinopathy (DR) and Diabetic Macular Oedema (DMO) provided by the Noctura 400 Light Mask., UK,2017-2018
  
  -BRIGHT Study, Multi-Centre, factorial, randomised controlled trial of alternative treatments to inhibit VEGF in Branch retinal vein Occlusion , Comparing Lucentis® (ranibizumub) with laser, steroid injection with respect to the benefits of vascular endothelial growth factor (VEGF) inhibition in maintaining/improving visual acuity in eyes with BRVO Royal Eye Infirmary Plymouth., UK, 2013
  
  -CRYSTAL Study, Multi-Centre, factorial, randomised controlled trial of alternative treatments to inhibit VEGF in Central vein Occlusion , Comparing Lucentis® (ranibizumub) to steroid injection and sham with respect to the benefits of vascular endothelial growth factor (VEGF) inhibition in maintaining/improving visual acuity in eyes with CRVO Royal Eye Infirmary Plymouth., UK, 2013
  
  -MERLOT Study multi-Centre, factorial, randomised controlled trial to evaluate the safety and efficacy of focal delivery of radiation for the treatment of subfoveal choroidal neovascularization (CNV) associated with established wet age-related macular degeneration (AMD) previously treated with anti-VEGF therapy Royal Eye Infirmary Plymouth., UK, 2012
  
  -IVAN Study, Multi-centre, factorial, randomised controlled trial of alternative treatments to inhibit VEGF in age-related choroidal neovascularisation ,Comparing Avastin® (bevacizumab) to Lucentis® (ranibizumub) with respect to the benefits of vascular endothelial growth factor (VEGF) inhibition in maintaining/improving visual acuity in eyes with choroidal neovascularisation (CNV). Wolverhampton Eye Hospital., UK, 2010
  PUBLICATIONS
  -Updated Retinal protocols for AMD, DMO, RVO and Myopic CNVM at Chelsea and Westminster Hospitals, London, submitted, 2018
  
  -Waqar S, Quinn A, Kasmiya M, the use of post Op. prophylactic antibiotic in Cataract Surgery, The Association for Research in Vision and Ophthalmology,ARVO,2009
  
  - Murjanah S,Waqar, Kasmiya M, the Use of Intracameral cefuroxime in Cataract Surgery, British Journal Of Ophthalmology BJO,2010
  
  
  -Hazarbassanov, W Quinn, Kasmiya M, BJO , efficacy of oral iverectin for treatment of chronic blepharitis in patients tested positive for Demodex Spp, 2011
  
  
  -Waqar, Kasmiya , J Jacob, Application of the ESCRS recommendations on antibiotics for postoperative endophthalmitis prophylaxis following cataract surgery in the UK,2010
  
  -Waqar S, Quinn A, Kasmiya M, the use of post Op. prophylactic antibiotic in Cataract Surgery, ARVO,2009

• Awards and recognitions icon plus

  Honorary Clinical Lecturer, Imperial College, Faculty of Medicine, London
  Bachelor of Medicine and Bachelor of Surgery ,Spain British Medical Association, UK,Gold and silver certificate of completion learning
  United Nations Scholarships for Academic Achievement

• Professional bodies icon plus

  Royal College of Ophthalmologists
  Royal College of Surgeons
  Royal Society of Medicine
  American Academy of Ophthalmology
  European Society of Retinal Specialists
  General Medical Council
  Medical Defence Union

• Approved insurers icon plus

  Bupa, Aviva, Vitality , Axa, Aetna Global